Emerging Trends in Personalized Medicine in COVID-19
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Molecular and Translational Medicine".
Deadline for manuscript submissions: closed (31 October 2023) | Viewed by 261
Special Issue Editor
Interests: mitochondria; cancer; chronic diseases; infectious disease
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear colleagues,
Personalized medicine is an emerging approach for effectiveness in treatment outcomes and toxicity for each COVID-19 patient. Autologous blood plasma and peripheral blood stem cells are a possible treatment for fulminant COVID-19 infection. Personalization has the potential to tailor therapy towards the pharmacogenomics, immunology and immunology genetics drivers of treatment outcome, and thus, on patients' quality of life. Furthermore, this could be the key to avoiding suboptimal drug dosing or adverse events, taking into account the genetic variability of each person, their sex and their age. This Special Issue, “Emerging Trends in Personalized Medicine in COVID-19”, will focus on personalized treatment in COVID-19 and long COVID research, including clinical, preclinical, pharmacological and translational trends .
Dr. Kieu C.D. Nguyễn
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
